Quarterly Net Revenue Increased 79% Year-Over-Year to $24.2 Million, the Highest Revenue in Company HistoryStrategic Priorities Focused on Driving Revenue...
Entered into $100 Million Private Placement AgreementFinalized pivotal Phase 3 trial design for gedatolisibReceived FDA Fast Track designation for gedatolisib...
TO SELL 44 CBD PRODUCTS IN THE UNITED KINGDOMUK Food Standards Agency (FSA) Validates Poko's ProductsUnder Novel Food ApplicationOnly FSA-Approved...
Q1 2022 revenue of $25.7 million, up 8% compared to Q1 2021Q1 2022 net loss of $2.1 million, compared to...
Calgary, Alberta--(Newsfile Corp. - May 16, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
Britannia Mining Solutions, will install and operate two Chrysos PhotonAssay™ units with the first unit to be delivered in H2...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 16, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or...
MOBILE, Ala.--(BUSINESS WIRE)--$CPSI--CPSI (NASDAQ: CPSI), a healthcare solutions company, welcomes over 800 attendees to its National Client Conference held May...
One of the nation’s largest independent neurology practices adopts athenaOne® solution to increase staff satisfaction and meet the evolving needs...
SAN JOSE, CA / ACCESSWIRE / May 16, 2022 / iSign Solutions Inc. ("iSIGN") (OTC Pink:ISGN), a leading supplier of...
VANCOUVER, BC / ACCESSWIRE / May 16, 2022 / Empower Clinics Inc. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (the "Company" or "Empower") is...
Data published in peer-reviewed journal, Science AdvancesCo-implantation of allogeneic islets and streptavidin (SA)-FasL-presenting microgels sustained long-term (>6 months) survival of...
REDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the...
Franchise Global to Acquire German Pharmaceutical and Medical Cannabis Products Distributor, Strengthening its Position in the German Pharmaceutical and Medical...
On track to report Phase 2 data for vurolenatide for short bowel syndrome and Phase 3 interim analysis for celiac...
Proceeds to Advance Clinical Development of Gedatolisib Including Forthcoming Phase 3 Clinical Study (VIKTORIA-1)MINNEAPOLIS, MN / ACCESSWIRE / May 16,...
FT. MYERS, FL / ACCESSWIRE / May 16, 2022 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused...
SHELTON, CT / ACCESSWIRE / May 16, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the...
ANN ARBOR, MI / ACCESSWIRE / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health...
MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader...